Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126485643 | 12648564 | 3 | F | 20160922 | 20160812 | 20160930 | EXP | CN-ASTRAZENECA-2016SE85178 | ASTRAZENECA | 67.00 | YR | M | Y | 0.00000 | 20160930 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126485643 | 12648564 | 1 | PS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | U | 19726 | 3.6 | MG | IMPLANT | |||||||
| 126485643 | 12648564 | 2 | SS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | U | 19726 | 3.6 | MG | IMPLANT | |||||||
| 126485643 | 12648564 | 3 | SS | CASODEX | BICALUTAMIDE | 1 | Oral | DAILY | 0 | TABLET | |||||||||
| 126485643 | 12648564 | 4 | C | CEREBROLYSIN | CEREBROLYSIN | 1 | 0 | ||||||||||||
| 126485643 | 12648564 | 5 | C | ASPIRIN. | ASPIRIN | 1 | ENTERIC-COATED TABLETS ONE TABLET DAILY | 0 | |||||||||||
| 126485643 | 12648564 | 6 | C | INDAPAMIDE. | INDAPAMIDE | 1 | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126485643 | 12648564 | 1 | Prostate cancer |
| 126485643 | 12648564 | 2 | Prostate cancer |
| 126485643 | 12648564 | 4 | Cerebral infarction |
| 126485643 | 12648564 | 5 | Hypertension |
| 126485643 | 12648564 | 6 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126485643 | 12648564 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126485643 | 12648564 | Malignant neoplasm progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126485643 | 12648564 | 1 | 20160210 | 0 | ||
| 126485643 | 12648564 | 2 | 20160831 | 0 | ||
| 126485643 | 12648564 | 3 | 20160205 | 0 |